Enoxaparin Clinical Trials
7 recruitingDrug
Phase 42Phase 22Phase 32Not Applicable1Phase 11
Showing 1–7 of 7 trials
Recruiting
Phase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905
Recruiting
Phase 1
A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
Healthy Participants
AstraZeneca186 enrolled2 locationsNCT07312851
Recruiting
Phase 4
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
ThrombocytopeniaCancer-associated Thrombosis
Tzu-Fei Wang50 enrolled4 locationsNCT05255003
Recruiting
Phase 4
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Head and Neck CancerVenous Thromboembolism
Kiranya Arnold76 enrolled1 locationNCT07189897
Recruiting
Phase 2Phase 3
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Deep Venous Thrombosis
Yale University258 enrolled22 locationsNCT04924322
Recruiting
Not Applicable
Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
Bariatric Surgery CandidateMorbid Obesity
Alexandria University162 enrolled1 locationNCT06689241
Recruiting
Phase 2
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Liver CirrhosisDecompensated Cirrhosis of LiverAcute on Chronic Liver Failure (ACLF)
European Foundation for Study of Chronic Liver Failure90 enrolled9 locationsNCT05895136